Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials

in short Ceftolozane 1g / Tazobactam 500mg inf vials

SNOMED code
31007811000001109
Active compound
Ceftolozane + Tazobactam
Preferred name basis
Other
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Tazobactam sodium, ID: 96007008 — 500 mg based on base substance
Ceftolozane sulfate, ID: 708792003 — 1 gram based on base substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd)

in short Zerbaxa 1g/0.5g pdr for concentrate for inf vials

Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials

SNOMED code
31007911000001104
Supplier
Merck Sharp & Dohme (UK) Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 10 vial
31008111000001101   ref. pack
💯 Available

Legal category: POM
5013945301595

End: 5013945303902

End: 00191778008913
00191778018448

End:
NHS Indicative Price
£670.30
• Hospital
  • • Prescription Charges

Reference packs

Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials 10 vial
SNOMED code
31008011000001102
Quantity and unit
10 vial
Packs